PHARMA

Dr. Agarwals Health Care Ltd shares move as SEBI receives takeover disclosure from Catalyst Trusteeship

By Hemanth Venugopal •
Catalyst Trusteeship Ltd, acting as a pledgee for Dr. Agarwals Health Care Ltd shares, filed a disclosure under SEBI’s takeover regulations (Regulation 29(2)) on August 13, 2026. This relates to a ...

Why did Dr. Agarwals Health Care Ltd shares jump today?

Dr. Agarwals Health Care Ltd shares saw a notable uptick today, rising 0.14% to trade at ₹509.0 as of Friday at 01:25 PM. The move came in the wake of a regulatory filing that brought important information regarding a major shareholding pledge to the market's attention.

The news stems from a disclosure filed by Catalyst Trusteeship Limited (CTL) with the stock exchanges. CTL is acting as a security agent for a loan facility. The core of the disclosure relates to a pledge of approximately 73.19 million equity shares of Dr. Agarwals Health Care. These shares were pledged by Hyperion Investments Pte. Ltd., the borrower in a loan agreement for up to $100 million, with CTL holding them as collateral.

This kind of filing under SEBI's takeover regulations is a routine compliance requirement. It essentially confirms the continuation of an existing pledge arrangement rather than signaling a new transaction. For the market, such disclosures provide transparency about large, pledged share blocks, and the lack of any adverse change in this existing arrangement may have contributed to the positive investor sentiment and the subsequent price movement today.

What does Dr. Agarwals Health Care Ltd do?

Dr. Agarwals Health Care Ltd is a publicly listed company, as evidenced by the disclosure requirements to the BSE Limited and the National Stock Exchange of India Limited. The company's registered office is located in Chennai, Tamil Nadu.

It is identified as the "Target Company" in relation to a significant financial facility. Equity shares of the company were pledged by an investor, Hyperion Investments Pte. Ltd., as security for a facility agreement valued at up to USD 100,000,000.

Dr. Agarwals Health Care Ltd Financials

In Crores
564
40
Mar 2026
614
45
Jun 2026
Revenue
Net Profit

Dr. Agarwals Health Care Ltd demonstrated positive financial growth between the quarters ending in March 2026 and June 2026. Revenue increased from ₹564.11 Crores to ₹614.02 Crores, marking a clear upward trend. Concurrently, profit rose from ₹39.71 Crores to ₹45.23 Crores over the same period, indicating improved profitability alongside top-line expansion.

Dr. Agarwals Health Care Ltd Shareholding Pattern

Holdings
Promoter
32.34%
FIIs
57.97%
DIIs
7.72%
Public
1.97%

Promoter holding stands at 32.34% of the total share capital. Foreign Institutional Investors (FIIs) hold 57.97% stake in the company, while Domestic Institutional Investors (DIIs) hold 7.72%. Public shareholders hold the remaining 1.97% stake in Dr. Agarwals Health Care Ltd.

Dr. Agarwals Health Care Ltd FAQs

Q: Why did Dr. shares jump 0.14% today?

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd. This corporate action caught investor attention, leading to increased trading activity in the stock.

Q: What is the shareholding pattern of Dr. Agarwals Health Care Ltd?

As per the latest data, promoters hold 32.34% stake in Dr. Agarwals Health Care Ltd, while FII holding stands at 57.97%. Domestic institutional investors hold 7.72%, and public shareholders account for 1.97% of the equity.

Q: What is the current stock price of Dr. Agarwals Health Care Ltd?

Dr. Agarwals Health Care Ltd shares are currently trading at ₹509.0, recording a gain of 0.14% from the previous close.

Q: What is the market capitalization of Dr. Agarwals Health Care Ltd?

The company currently has a market capitalization of ₹16136.63 crore, reflecting its valuation in the Indian equity market.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. The stock prices mentioned are as of the time of writing. Hemanth Venugopal and the publisher do not hold any positions in the stocks mentioned. Please consult a SEBI-registered financial advisor before making any investment decisions.